The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lubiprostone Market Research Report 2025
Synopsis
Lubiprostone (rINN, marketed under the trade name Amitiza among others) is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation.
The global Lubiprostone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Lubiprostone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lubiprostone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Lubiprostone in CIC and OIC is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Lubiprostone include Takeda Pharmaceuticals. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lubiprostone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lubiprostone.
Report Scope
The Lubiprostone market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lubiprostone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lubiprostone companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda Pharmaceuticals
Segment by Type
8 mcg Capsules
24 mcg Capsules
Segment by Application
CIC and OIC
IBS-C
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lubiprostone companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Lubiprostone (rINN, marketed under the trade name Amitiza among others) is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation.
The global Lubiprostone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Lubiprostone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lubiprostone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Lubiprostone in CIC and OIC is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Lubiprostone include Takeda Pharmaceuticals. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lubiprostone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lubiprostone.
Report Scope
The Lubiprostone market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lubiprostone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lubiprostone companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda Pharmaceuticals
Segment by Type
8 mcg Capsules
24 mcg Capsules
Segment by Application
CIC and OIC
IBS-C
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lubiprostone companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lubiprostone Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 8 mcg Capsules
1.2.3 24 mcg Capsules
1.3 Market by Application
1.3.1 Global Lubiprostone Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 CIC and OIC
1.3.3 IBS-C
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lubiprostone Market Perspective (2019-2030)
2.2 Lubiprostone Growth Trends by Region
2.2.1 Global Lubiprostone Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Lubiprostone Historic Market Size by Region (2019-2024)
2.2.3 Lubiprostone Forecasted Market Size by Region (2025-2030)
2.3 Lubiprostone Market Dynamics
2.3.1 Lubiprostone Industry Trends
2.3.2 Lubiprostone Market Drivers
2.3.3 Lubiprostone Market Challenges
2.3.4 Lubiprostone Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lubiprostone Players by Revenue
3.1.1 Global Top Lubiprostone Players by Revenue (2019-2024)
3.1.2 Global Lubiprostone Revenue Market Share by Players (2019-2024)
3.2 Global Lubiprostone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lubiprostone Revenue
3.4 Global Lubiprostone Market Concentration Ratio
3.4.1 Global Lubiprostone Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lubiprostone Revenue in 2023
3.5 Lubiprostone Key Players Head office and Area Served
3.6 Key Players Lubiprostone Product Solution and Service
3.7 Date of Enter into Lubiprostone Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lubiprostone Breakdown Data by Type
4.1 Global Lubiprostone Historic Market Size by Type (2019-2024)
4.2 Global Lubiprostone Forecasted Market Size by Type (2025-2030)
5 Lubiprostone Breakdown Data by Application
5.1 Global Lubiprostone Historic Market Size by Application (2019-2024)
5.2 Global Lubiprostone Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Lubiprostone Market Size (2019-2030)
6.2 North America Lubiprostone Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Lubiprostone Market Size by Country (2019-2024)
6.4 North America Lubiprostone Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lubiprostone Market Size (2019-2030)
7.2 Europe Lubiprostone Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Lubiprostone Market Size by Country (2019-2024)
7.4 Europe Lubiprostone Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lubiprostone Market Size (2019-2030)
8.2 Asia-Pacific Lubiprostone Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Lubiprostone Market Size by Region (2019-2024)
8.4 Asia-Pacific Lubiprostone Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lubiprostone Market Size (2019-2030)
9.2 Latin America Lubiprostone Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Lubiprostone Market Size by Country (2019-2024)
9.4 Latin America Lubiprostone Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lubiprostone Market Size (2019-2030)
10.2 Middle East & Africa Lubiprostone Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Lubiprostone Market Size by Country (2019-2024)
10.4 Middle East & Africa Lubiprostone Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceuticals
11.1.1 Takeda Pharmaceuticals Company Detail
11.1.2 Takeda Pharmaceuticals Business Overview
11.1.3 Takeda Pharmaceuticals Lubiprostone Introduction
11.1.4 Takeda Pharmaceuticals Revenue in Lubiprostone Business (2019-2024)
11.1.5 Takeda Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Lubiprostone Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 8 mcg Capsules
Table 3. Key Players of 24 mcg Capsules
Table 4. Global Lubiprostone Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Lubiprostone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Lubiprostone Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Lubiprostone Market Share by Region (2019-2024)
Table 8. Global Lubiprostone Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Lubiprostone Market Share by Region (2025-2030)
Table 10. Lubiprostone Market Trends
Table 11. Lubiprostone Market Drivers
Table 12. Lubiprostone Market Challenges
Table 13. Lubiprostone Market Restraints
Table 14. Global Lubiprostone Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Lubiprostone Market Share by Players (2019-2024)
Table 16. Global Top Lubiprostone Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lubiprostone as of 2023)
Table 17. Ranking of Global Top Lubiprostone Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Lubiprostone Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Lubiprostone Product Solution and Service
Table 21. Date of Enter into Lubiprostone Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Lubiprostone Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Lubiprostone Revenue Market Share by Type (2019-2024)
Table 25. Global Lubiprostone Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Lubiprostone Revenue Market Share by Type (2025-2030)
Table 27. Global Lubiprostone Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Lubiprostone Revenue Market Share by Application (2019-2024)
Table 29. Global Lubiprostone Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Lubiprostone Revenue Market Share by Application (2025-2030)
Table 31. North America Lubiprostone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Lubiprostone Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Lubiprostone Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Lubiprostone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Lubiprostone Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Lubiprostone Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Lubiprostone Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Lubiprostone Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Lubiprostone Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Lubiprostone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Lubiprostone Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Lubiprostone Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Lubiprostone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Lubiprostone Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Lubiprostone Market Size by Country (2025-2030) & (US$ Million)
Table 46. Takeda Pharmaceuticals Company Detail
Table 47. Takeda Pharmaceuticals Business Overview
Table 48. Takeda Pharmaceuticals Lubiprostone Product
Table 49. Takeda Pharmaceuticals Revenue in Lubiprostone Business (2019-2024) & (US$ Million)
Table 50. Takeda Pharmaceuticals Recent Development
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lubiprostone Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Lubiprostone Market Share by Type: 2023 VS 2030
Figure 3. 8 mcg Capsules Features
Figure 4. 24 mcg Capsules Features
Figure 5. Global Lubiprostone Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Lubiprostone Market Share by Application: 2023 VS 2030
Figure 7. CIC and OIC Case Studies
Figure 8. IBS-C Case Studies
Figure 9. Lubiprostone Report Years Considered
Figure 10. Global Lubiprostone Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Lubiprostone Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Lubiprostone Market Share by Region: 2023 VS 2030
Figure 13. Global Lubiprostone Market Share by Players in 2023
Figure 14. Global Top Lubiprostone Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lubiprostone as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Lubiprostone Revenue in 2023
Figure 16. North America Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Lubiprostone Market Share by Country (2019-2030)
Figure 18. United States Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Lubiprostone Market Share by Country (2019-2030)
Figure 22. Germany Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Lubiprostone Market Share by Region (2019-2030)
Figure 30. China Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Lubiprostone Market Share by Country (2019-2030)
Figure 38. Mexico Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Lubiprostone Market Share by Country (2019-2030)
Figure 42. Turkey Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Lubiprostone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Takeda Pharmaceuticals Revenue Growth Rate in Lubiprostone Business (2019-2024)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
